Calendar

pharmadog

Week of Apr 6, 2026

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: BIOCON PHARMA. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — FDA approvalDAPAGLIFLOZIN

Sponsor: AUROBINDO PHARMA. Form: TABLET

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

Sponsor: INVENTIA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

Sponsor: AIZANT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: CIPLA. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: CIPLA LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: TORRENT. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MACLEODS PHARMS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: LUPIN LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: TEVA PHARMS USA INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: CIPLA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026approval146d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026approval146d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: SANDOZ. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval146d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026approval146d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

04/07/2026recall145d agoDTF Sexual Chocolate recall: Food & Beverages

Chocolate

full page →fda recalls ↗

Apr 7, 2026approval145d agoNITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN) — FDA approvalCreekwood Pharmaceutical Inc

Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 7, 2026approval145d agoBEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalnirsevimab

Sponsor: ASTRAZENECA AB. Form: INJECTABLE. Route: INJECTION

full page →nirsevimab →fda approvals ↗

Apr 7, 2026approval145d agoPLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvallutetium Lu 177 vipivotide tetraxetan

Sponsor: NOVARTIS. Form: SOLUTION. Route: INTRAVENOUS

full page →lutetium Lu 177 vipivotide tetraxetan →fda approvals ↗

Apr 7, 2026approval145d agoIVERMECTIN — FDA approvalIVERMECTIN

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →IVERMECTIN →fda approvals ↗

Apr 7, 2026approval145d agoSKYCLARYS (OMAVELOXOLONE) — FDA approvalReata Pharmaceuticals Inc

Sponsor: BIOGEN US. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 7, 2026approval145d agoCEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approvalSamson Medical Technologies LLC

Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 7, 2026approval145d agoEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE) — FDA approvalemtricitabine

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →emtricitabine →fda approvals ↗

04/08/2026recall144d agoRevitaderm, Tridergel recall: Drugs

Antiseptic wound care gel bottles and tubes

full page →fda recalls ↗

Apr 8, 2026approval144d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Apr 8, 2026approval144d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 8, 2026approval144d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 8, 2026approval144d agoINGREZZA SPRINKLE (VALBENAZINE TOSYLATE) — FDA approvalVALBENAZINE TOSYLATE

Sponsor: NEUROCRINE. Form: CAPSULE. Route: ORAL

full page →VALBENAZINE TOSYLATE →fda approvals ↗

Apr 8, 2026approval144d agoHALOPERIDOL — FDA approvalHALOPERIDOL

Sponsor: AIPING PHARM INC. Form: TABLET. Route: ORAL

full page →HALOPERIDOL →fda approvals ↗

Apr 8, 2026approval144d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Apr 8, 2026approval144d agoOFLOXACIN — FDA approvalOFLOXACIN

Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →OFLOXACIN →fda approvals ↗

Apr 8, 2026approval144d agoPROGESTERONE — FDA approvalPROGESTERONE

Sponsor: GLENMARK PHARMS LTD. Form: INSERT. Route: VAGINAL

full page →PROGESTERONE →fda approvals ↗

Apr 8, 2026approval144d agoELTROMBOPAG OLAMINE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: ZENARA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 8, 2026recall144d agoAppco Pharma LLC recall (Cls II)Appco Pharma LLC

Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-066-11. — Reason: cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. — Status: Ongoing

full page →fda recalls ↗

← prev

page 399 of 403

Week of Apr 6, 2026